logo

For the Inventor, By the Inventor

Springfield, VA, United States of America

Mark Cosentino

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: The University of North Carolina at Chapel Hill, Biotech Research Laboratories, Other. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Cosentino. Retrieved from https://idiyas.com/inventor/mark-cosentino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:

goldMedal3 out of 1,331 
 
The University of North Carolina at Chapel Hill
 patents
silverMedal2 out of 8 
 
Biotech Research Laboratories
 patents
bronzeMedal1 out of 834,659 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2001

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 6319929 - Suksdorfin analogs, compositions thereof, and methods for making and using thereof (2001-11-20),
2. 5847165 - Suksdorfin analogs, compositions thereof, and methods for making and (1998-12-08),
3. 5726204 - Suksdorfin analogs, compositions thereof, and methods for making and (1998-03-10),
4. 5637589 - Suksdorfin, analogs, compositions thereof, and methods for making and (1997-06-10),

Title: Mark Cosentino: Innovator in Pharmaceutical Chemistry

Introduction

Mark Cosentino is a notable inventor based in Springfield, VA (US), recognized for his contributions to pharmaceutical chemistry. With a total of 4 patents, he has made significant strides in the development of compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention titled "Suksdorfin analogs, compositions thereof, and methods for making and using thereof." This invention focuses on compounds that are analogs of the natural product suksdorfin. The compounds include those represented by a specific formula, which are designed to treat retroviral infections. Additionally, the patent describes a stereoselective method for synthesizing these compounds, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Mark Cosentino has worked with esteemed institutions such as the University of North Carolina at Chapel Hill and Biotech Research Laboratories. His work in these organizations has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Throughout his career, Mark has collaborated with notable professionals, including Kuo-Hsiung Lee and Lan Xie. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Mark Cosentino's work in developing pharmaceutical compounds demonstrates his commitment to innovation in the field of chemistry. His patents and collaborations reflect a dedication to advancing medical science and improving treatment options for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…